1. Factors Influencing Placebo Responses in Rheumatoid Arthritis Clinical Trials: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Studies

   • Kota Nagai
   • Keisuke Matsubayashi
   • Koji Kawakami

   Systematic Review 17 January 2020 Pages: 197 - 209

   

2. Systemic Treatment for Metastatic Hormone Sensitive Prostate Cancer: A Comprehensive Meta-Analysis Evaluating Efficacy and Safety in Specific Sub-Groups of Patients

   • Vincenzo Di Nunno
   • Matteo Santoni
   • Francesco Massari

   Systematic Review 28 January 2020 Pages: 211 - 226

   

3. Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports

   • David Martínez-Cuadrón
   • Gabriela Rodríguez-Macías
   • Pau Montesinos

   Practical Application Open access 07 January 2020 Pages: 227 - 235

   

4. Food Effect on a Single High Dose of Carotegrast Methyl, an Oral Antagonist of α4-Integrin, in Healthy Male Subjects: A Randomised, Placebo-Controlled, Double-Blind Study

   • Hiroyuki Fukase
   • Toshifumi Kajioka
   • Hidetoshi Furuie

   Original Research Article Open access 22 January 2020 Pages: 237 - 247

   

5. Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial

   • Ebrahim Salehifar
   • Ghasem Janbabaei
   • Razieh Avan

   Original Research Article 10 January 2020 Pages: 249 - 257

   

6. Clinical Pharmacokinetics, Safety and Exploratory Efficacy Study of a Topical Bactericidal VB-1953: Analysis of Single and Multiple Doses in a Phase I Trial in Acne Vulgaris Subjects

   • Shilpi Jain
   • Vishal Yadav
   • Neal Bhatia

   Original Research Article 11 January 2020 Pages: 259 - 268

   

7. Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS)

   • Xenofon Baraliakos
   • Mikkel Østergaard
   • the SURPASS Study Group

   Original Research Article 25 January 2020 Pages: 269 - 278

   

8. Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies

   • Antonio Pecoraro
   • Silvia Ricci
   • For the SHIFT and IBIS Study Groups

   Short Communication Open access 08 February 2020 Pages: 279 - 286

   

9. Comment On: “Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study”

   • Nameer van Oosterom
   • Karl Winckel
   • Michael Barras

   Letter to the Editor 03 February 2020 Pages: 287 - 288

10. Response to Comment on: “Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study”

    • Young R. Lee

    Letter to the Editor 03 February 2020 Pages: 289 - 290

11. Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features

    • Katherine A. Lyseng-Williamson

    Correction Open access 10 February 2020 Pages: 291 - 291